Home » Spectrum Gets $16 Million From Asian Partners for Apaziquone Collaboration
Spectrum Gets $16 Million From Asian Partners for Apaziquone Collaboration
Spectrum Pharmaceuticals, Inc. has announced that it has received
$15 million from Nippon Kayaku in connection with the collaboration agreement for apaziquone (EOquin) announced on November 10, and $1 million from Handok
Pharmaceuticals announced on November 23.
TradingMarkets
TradingMarkets
Upcoming Events
-
07May
-
14May
-
30May